消化

MedSci主页 / 所有栏目 / 消化

奥美拉唑与这26种药物的配伍禁忌，不可不知！

2022-05-26 医学之声医学之声

消化新前沿

合理用药~

在临床中，奥美拉唑是一种常用药物，通常有注射制剂、口服制剂两种剂型，因此在临床中使用时需掌握其配伍禁忌。

1. 与氢氯吡格雷合用

2. 与双歧杆菌活菌合用

3. 与维生素B12合用

4. 与炔丙雌醇合用

5. 与华法林钠合用

6. 与苯二氮卓类合用

7. 与地高辛合用

8. 与卡马西平合用

9. 与铁剂合用

10. 与西洛他唑合用

11. 与硝苯地平合用

12. 与盐酸麻黄碱合用

13. 与酮康唑合用

14. 与甲氨蝶呤合用

15. 与苯海索合用

16. 与地塞米松合用

17. 与伏立康唑合用

18. 与泼尼松合用

19. 与伊曲康唑合用

20. 与帕罗西汀合用

21. 与长春西汀配伍

22. 与氨甲环酸配伍

23. 与复方氨基酸配伍

24. 与盐酸氨溴索配伍

25. 与奥硝唑配伍

26. 与磷酸川芎嗪配伍

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (3)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1942410, encodeId=d3aa1942410ad, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Wed Jan 04 19:11:49 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1284415, encodeId=eb9212844154a, content=<a href='/topic/show?id=3db5445e031' target=_blank style='color:#2F92EE;'>#奥美拉唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44570, encryptionId=3db5445e031, topicName=奥美拉唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Sat May 28 10:11:49 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545132, encodeId=bc88154513207, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sat May 28 10:11:49 CST 2022, time=2022-05-28, status=1, ipAttribution=)]
2023-01-04 zgwhgch

#配伍禁忌#

40 0
[GetPortalCommentsPageByObjectIdResponse(id=1942410, encodeId=d3aa1942410ad, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Wed Jan 04 19:11:49 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1284415, encodeId=eb9212844154a, content=<a href='/topic/show?id=3db5445e031' target=_blank style='color:#2F92EE;'>#奥美拉唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44570, encryptionId=3db5445e031, topicName=奥美拉唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Sat May 28 10:11:49 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545132, encodeId=bc88154513207, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sat May 28 10:11:49 CST 2022, time=2022-05-28, status=1, ipAttribution=)]
2022-05-28 freve

#奥美拉唑#

38 0
[GetPortalCommentsPageByObjectIdResponse(id=1942410, encodeId=d3aa1942410ad, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Wed Jan 04 19:11:49 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1284415, encodeId=eb9212844154a, content=<a href='/topic/show?id=3db5445e031' target=_blank style='color:#2F92EE;'>#奥美拉唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44570, encryptionId=3db5445e031, topicName=奥美拉唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Sat May 28 10:11:49 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545132, encodeId=bc88154513207, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sat May 28 10:11:49 CST 2022, time=2022-05-28, status=1, ipAttribution=)]
2022-05-28 医者仁心

#禁忌#

34 0

相关资讯

科室
- - 订阅+
  - 更多科室
工具
服务